查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1769935

臉部注射劑市場（產品類型：真皮填充劑、肉毒桿菌、富血小板血漿、脫氧膽酸等）－2025-2035 年全球產業分析、規模、佔有率、成長、趨勢及預測

Facial Injectables Market (Product Type: Dermal Fillers, Botulinum Toxin, Platelet-Rich Plasma, Deoxycholic Acid, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

臉部注射劑市場-報告範圍

TMR 的全球臉部注射劑市場報告研究了過去和目前的成長趨勢及機遇，旨在深入了解 2025 年至 2035 年預測期內的市場指標。該報告提供了 2019 年至 2035 年期間全球臉部注射劑市場的收入，以 2025 年為基準年，2035 年為預測年。該報告還提供了 2025 年至 2035 年全球臉部注射劑市場的年複合成長率(CAGR%)。

本報告經過廣泛的調查後編寫。主要研究工作包括分析師對關鍵意見領袖、產業領袖和輿論領袖的訪談。次要研究則參考了主要參與者的產品資料、年度報告、新聞稿和相關文件，以了解臉部注射劑市場。

市場概況
2024 年的市場價值 103億美元
2035年的市場價值 270億美元
複合年成長率 9.2%

本報告深入探討了全球臉部注射劑市場的競爭格局。報告確定了全球臉部注射劑市場的主要參與者，並根據不同屬性對每家公司進行了分析。本報告對全球臉部注射劑市場參與者的屬性進行了分析，包括公司概況、財務狀況、近期發展和 SWOT 分析。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020 年至 2035 年全球臉部注射劑市場分析與預測

第5章：關鍵見解

  • 重要產業事件（合作夥伴關係、協作、產品核准、合併與收購）
  • 產品/品牌分析
  • 定價分析
  • 技術進步
  • PESTEL分析
  • 主要國家/地區監管情況
  • 波特五力分析
  • 主要國家報銷情況
  • 最終用戶的關鍵購買指標
  • 新市場進入者的市場進入策略

第6章：全球市場分析與預測：依產品類型

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2020 年至 2035 年
    • 真皮填充劑
      • 透明質酸（HA）
      • 羥基磷灰石鈣（CaHA）
      • 聚左旋乳酸（PLLA）
      • 聚甲基丙烯酸甲酯（PMMA）
      • 其他
    • 肉毒桿菌毒素
    • 富血小板血漿（PRP）
    • 脫氧膽酸
    • 其他
  • 市場吸引力分析：按產品類型

第7章：全球市場分析與預測：依性別

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依性別，2020年至2035年
    • 男性
    • 女性
  • 市場吸引力分析：按性別

第8章：全球市場分析與預測：按應用

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按應用，2020 年至 2035 年
    • 臉部線條矯正
    • 豐唇
    • 疤痕治療
    • 臉部拉皮
    • 臉部豐盈
    • 其他
  • 市場吸引力分析：按應用

第9章：全球市場分析與預測：按最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020 年至 2035 年
    • 醫院
    • 皮膚科診所
    • 醫療水療中心
    • 其他
  • 市場吸引力分析：按最終用戶

第10章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020年至2035年
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第 11 章：北美市場分析與預測

第12章：歐洲市場分析與預測

第13章：亞太市場分析與預測

第14章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第 16 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • AbbVie Inc. (Allergan Aesthetics)
    • Anika Therapeutics, Inc.
    • Bioplus Co., Ltd.
    • BIOXIS Pharmaceuticals
    • Bloomage Biotech Co., Ltd
    • Galderma
    • Sinclair Pharma
    • Revance Therapeutics, Inc.
    • Merz Pharma GmbH & Co. KGaA
    • Prollenium Medical Technologies Inc.
    • Teoxane SA
    • Croma-Pharma GmbH
    • Fidia Pharma USA Inc.
    • Tiger Aesthetics Medical, LLC
Product Code: TMRGL1779

Facial Injectables Market - Scope of Report

TMR's report on the global facial injectables market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global facial injectables market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global facial injectables market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the facial injectables market.

Market Snapshot
Market Value in 2024US$ 10.3 Bn
Market Value in 2035US$ 27 Bn
CAGR9.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global facial injectables market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global facial injectables market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global facial injectables market.

The report delves into the competitive landscape of the global facial injectables market. Key players operating in the global facial injectables market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global facial injectables market profiled in this report.

Key Questions Answered in Global facial injectables market Report:

  • What is the sales/revenue generated by apheresis across all regions during the forecast period?
  • What are the opportunities in the global facial injectables market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Facial Injectables Market - Research Objectives and Research Approach

The comprehensive report on the global facial injectables market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global facial injectables market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global facial injectables market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Facial Injectables Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Facial Injectables Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
  • 5.2. Product/Brand Analysis
  • 5.3. Pricing Analysis
  • 5.4. Technological Advancements
  • 5.5. PESTEL Analysis
  • 5.6. Regulatory Scenario by Key Countries/Regions
  • 5.7. Porter's Five Forces Analysis
  • 5.8. Reimbursement Scenario by Key Countries
  • 5.9. Key Purchase Metrics for End-users
  • 5.10. Go-to-Market Strategy for New Market Entrants

6. Global Facial Injectables Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2020 to 2035
    • 6.3.1. Dermal Fillers
      • 6.3.1.1. Hyaluronic acid (HA)
      • 6.3.1.2. Calcium hydroxylapatite (CaHA)
      • 6.3.1.3. Poly-L-lactic acid (PLLA)
      • 6.3.1.4. Polymethylmethacrylate (PMMA)
      • 6.3.1.5. Others
    • 6.3.2. Botulinum Toxin
    • 6.3.3. Platelet-Rich Plasma (PRP)
    • 6.3.4. Deoxycholic Acid
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Facial Injectables Market Analysis and Forecast, by Gender

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Gender, 2020 to 2035
    • 7.3.1. Male
    • 7.3.2. Female
  • 7.4. Market Attractiveness Analysis, by Gender

8. Global Facial Injectables Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020 to 2035
    • 8.3.1. Facial Line Correction
    • 8.3.2. Lip Augmentation
    • 8.3.3. Scar Treatment
    • 8.3.4. Face Lift
    • 8.3.5. Facial Volume Enhancement
    • 8.3.6. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Facial Injectables Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020 to 2035
    • 9.3.1. Hospitals
    • 9.3.2. Dermatology Clinics
    • 9.3.3. MedSpas
    • 9.3.4. Others
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Facial Injectables Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020 to 2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Facial Injectables Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 11.2.1. Dermal Fillers
      • 11.2.1.1. Hyaluronic acid (HA)
      • 11.2.1.2. Calcium hydroxylapatite (CaHA)
      • 11.2.1.3. Poly-L-lactic acid (PLLA)
      • 11.2.1.4. Polymethylmethacrylate (PMMA)
      • 11.2.1.5. Others
    • 11.2.2. Botulinum Toxin
    • 11.2.3. Platelet-Rich Plasma (PRP)
    • 11.2.4. Deoxycholic Acid
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Gender, 2020 to 2035
    • 11.3.1. Male
    • 11.3.2. Female
  • 11.4. Market Value Forecast, by Application, 2020 to 2035
    • 11.4.1. Facial Line Correction
    • 11.4.2. Lip Augmentation
    • 11.4.3. Scar Treatment
    • 11.4.4. Face Lift
    • 11.4.5. Facial Volume Enhancement
    • 11.4.6. Others
  • 11.5. Market Value Forecast, by End-user, 2020 to 2035
    • 11.5.1. Hospitals
    • 11.5.2. Dermatology Clinics
    • 11.5.3. MedSpas
    • 11.5.4. Others
  • 11.6. Market Value Forecast, by Country, 2020 to 2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Gender
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Facial Injectables Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 12.2.1. Dermal Fillers
      • 12.2.1.1. Hyaluronic acid (HA)
      • 12.2.1.2. Calcium hydroxylapatite (CaHA)
      • 12.2.1.3. Poly-L-lactic acid (PLLA)
      • 12.2.1.4. Polymethylmethacrylate (PMMA)
      • 12.2.1.5. Others
    • 12.2.2. Botulinum Toxin
    • 12.2.3. Platelet-Rich Plasma (PRP)
    • 12.2.4. Deoxycholic Acid
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Gender, 2020 to 2035
    • 12.3.1. Male
    • 12.3.2. Female
  • 12.4. Market Value Forecast, by Application, 2020 to 2035
    • 12.4.1. Facial Line Correction
    • 12.4.2. Lip Augmentation
    • 12.4.3. Scar Treatment
    • 12.4.4. Face Lift
    • 12.4.5. Facial Volume Enhancement
    • 12.4.6. Others
  • 12.5. Market Value Forecast, by End-user, 2020 to 2035
    • 12.5.1. Hospitals
    • 12.5.2. Dermatology Clinics
    • 12.5.3. MedSpas
    • 12.5.4. Others
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Gender
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Facial Injectables Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 13.2.1. Dermal Fillers
      • 13.2.1.1. Hyaluronic acid (HA)
      • 13.2.1.2. Calcium hydroxylapatite (CaHA)
      • 13.2.1.3. Poly-L-lactic acid (PLLA)
      • 13.2.1.4. Polymethylmethacrylate (PMMA)
      • 13.2.1.5. Others
    • 13.2.2. Botulinum Toxin
    • 13.2.3. Platelet-Rich Plasma (PRP)
    • 13.2.4. Deoxycholic Acid
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Gender, 2020 to 2035
    • 13.3.1. Male
    • 13.3.2. Female
  • 13.4. Market Value Forecast, by Application, 2020 to 2035
    • 13.4.1. Facial Line Correction
    • 13.4.2. Lip Augmentation
    • 13.4.3. Scar Treatment
    • 13.4.4. Face Lift
    • 13.4.5. Facial Volume Enhancement
    • 13.4.6. Others
  • 13.5. Market Value Forecast, by End-user, 2020 to 2035
    • 13.5.1. Hospitals
    • 13.5.2. Dermatology Clinics
    • 13.5.3. MedSpas
    • 13.5.4. Others
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Gender
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Facial Injectables Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 14.2.1. Dermal Fillers
      • 14.2.1.1. Hyaluronic acid (HA)
      • 14.2.1.2. Calcium hydroxylapatite (CaHA)
      • 14.2.1.3. Poly-L-lactic acid (PLLA)
      • 14.2.1.4. Polymethylmethacrylate (PMMA)
      • 14.2.1.5. Others
    • 14.2.2. Botulinum Toxin
    • 14.2.3. Platelet-Rich Plasma (PRP)
    • 14.2.4. Deoxycholic Acid
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Gender, 2020 to 2035
    • 14.3.1. Male
    • 14.3.2. Female
  • 14.4. Market Value Forecast, by Application, 2020 to 2035
    • 14.4.1. Facial Line Correction
    • 14.4.2. Lip Augmentation
    • 14.4.3. Scar Treatment
    • 14.4.4. Face Lift
    • 14.4.5. Facial Volume Enhancement
    • 14.4.6. Others
  • 14.5. Market Value Forecast, by End-user, 2020 to 2035
    • 14.5.1. Hospitals
    • 14.5.2. Dermatology Clinics
    • 14.5.3. MedSpas
    • 14.5.4. Others
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Gender
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Facial Injectables Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2020 to 2035
    • 15.2.1. Dermal Fillers
      • 15.2.1.1. Hyaluronic acid (HA)
      • 15.2.1.2. Calcium hydroxylapatite (CaHA)
      • 15.2.1.3. Poly-L-lactic acid (PLLA)
      • 15.2.1.4. Polymethylmethacrylate (PMMA)
      • 15.2.1.5. Others
    • 15.2.2. Botulinum Toxin
    • 15.2.3. Platelet-Rich Plasma (PRP)
    • 15.2.4. Deoxycholic Acid
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Gender, 2020 to 2035
    • 15.3.1. Male
    • 15.3.2. Female
  • 15.4. Market Value Forecast, by Application, 2020 to 2035
    • 15.4.1. Facial Line Correction
    • 15.4.2. Lip Augmentation
    • 15.4.3. Scar Treatment
    • 15.4.4. Face Lift
    • 15.4.5. Facial Volume Enhancement
    • 15.4.6. Others
  • 15.5. Market Value Forecast, by End-user, 2020 to 2035
    • 15.5.1. Hospitals
    • 15.5.2. Dermatology Clinics
    • 15.5.3. MedSpas
    • 15.5.4. Others
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Gender
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. AbbVie Inc. (Allergan Aesthetics)
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. Anika Therapeutics, Inc.
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Bioplus Co., Ltd.
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. BIOXIS Pharmaceuticals
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Bloomage Biotech Co., Ltd
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Galderma
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Sinclair Pharma
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Revance Therapeutics, Inc.
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. Merz Pharma GmbH & Co. KGaA
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. Prollenium Medical Technologies Inc.
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. Teoxane SA
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. Croma-Pharma GmbH
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Fidia Pharma USA Inc.
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Tiger Aesthetics Medical, LLC
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments

List of Tables

  • Table 01: Global Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 02: Global Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 03: Global Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 04: Global Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 06: Global Facial Injectables Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 07: North America Facial Injectables Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 08: North America Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 09: North America Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 10: North America Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 11: North America Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 12: North America Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 13: Europe Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 14: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 15: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 16: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 17: Europe Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 18: Europe Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 19: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 20: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 21: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 22: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 23: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 24: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Latin America Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 27: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 28: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 29: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Latin America Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 31: Middle East & Africa Facial Injectables Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 32: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Product Type, 2020 to 2035
  • Table 33: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Dermal Fillers, 2020 to 2035
  • Table 34: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Gender, 2020 to 2035
  • Table 35: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 36: Middle East and Africa Facial Injectables Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 03: Global Facial Injectables Market Revenue (US$ Bn), by Dermal Fillers, 2020 to 2035
  • Figure 04: Global Facial Injectables Market Revenue (US$ Bn), by Botulinum Toxin, 2020 to 2035
  • Figure 05: Global Facial Injectables Market Revenue (US$ Bn), by Platelet-Rich Plasma (PRP), 2020 to 2035
  • Figure 06: Global Facial Injectables Market Revenue (US$ Bn), by Deoxycholic Acid, 2020 to 2035
  • Figure 07: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 08: Global Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 09: Global Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 10: Global Facial Injectables Market Revenue (US$ Bn), by Male, 2020 to 2035
  • Figure 11: Global Facial Injectables Market Revenue (US$ Bn), by Female, 2020 to 2035
  • Figure 12: Global Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 13: Global Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 14: Global Facial Injectables Market Revenue (US$ Bn), by Facial Line Correction, 2020 to 2035
  • Figure 15: Global Facial Injectables Market Revenue (US$ Bn), by Lip Augmentation, 2020 to 2035
  • Figure 16: Global Facial Injectables Market Revenue (US$ Bn), by Scar Treatment, 2020 to 2035
  • Figure 17: Global Facial Injectables Market Revenue (US$ Bn), by Face Lift, 2020 to 2035
  • Figure 18: Global Facial Injectables Market Revenue (US$ Bn), by Facial Volume Enhancement, 2020 to 2035
  • Figure 19: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 20: Global Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 21: Global Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 22: Global Facial Injectables Market Revenue (US$ Bn), by Hospitals, 2020 to 2035
  • Figure 23: Global Facial Injectables Market Revenue (US$ Bn), by Dermatology Clinics, 2020 to 2035
  • Figure 24: Global Facial Injectables Market Revenue (US$ Bn), by MedSpas, 2020 to 2035
  • Figure 25: Global Facial Injectables Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 26: Global Facial Injectables Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 27: Global Facial Injectables Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 28: North America Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 29: North America Facial Injectables Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 30: North America Facial Injectables Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 31: North America Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 32: North America Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 33: North America Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 34: North America Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 35: North America Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 36: North America Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 37: North America Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 38: North America Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 39: Europe Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 40: Europe Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 41: Europe Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 42: Europe Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 43: Europe Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 44: Europe Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 45: Europe Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 46: Europe Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 47: Europe Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 48: Europe Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 49: Europe Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 50: Asia Pacific Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 51: Asia Pacific Facial Injectables Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 52: Asia Pacific Facial Injectables Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 53: Asia Pacific Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 54: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 55: Asia Pacific Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 56: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 57: Asia Pacific Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 58: Asia Pacific Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 59: Asia Pacific Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 60: Asia Pacific Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 61: Latin America Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 62: Latin America Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 63: Latin America Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 64: Latin America Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 65: Latin America Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 66: Latin America Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 67: Latin America Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 68: Latin America Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 69: Latin America Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 70: Latin America Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 71: Latin America Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 72: Middle East & Africa Facial Injectables Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 73: Middle East & Africa Facial Injectables Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 74: Middle East & Africa Facial Injectables Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 75: Middle East and Africa Facial Injectables Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 76: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Product Type, 2025 to 2035
  • Figure 77: Middle East and Africa Facial Injectables Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 78: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Gender, 2025 to 2035
  • Figure 79: Middle East and Africa Facial Injectables Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 80: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 81: Middle East and Africa Facial Injectables Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 82: Middle East and Africa Facial Injectables Market Attractiveness Analysis, By End-user, 2025 to 2035